33 C
New York
Thursday, June 11, 2026

Tag: personalization

newssourceFORcompanyinformationcontent1marketreleases

Target Announces “Back-to-School-idays” Savings Event with Deals on New Must-Have School Items

The back-to-school savings event runs July 27-Aug. 2 in stores and on Target.com The retailer will offer savings on hundreds of back-to-school items, plus deals...

Italian Premium Fashion-Sport Brand Hydrogen Enters China Market in Partnership with BranDNA

SHANGHAI, July 22, 2025 /PRNewswire/ -- BranDNA announced a strategic partnership with CREAS F&C to launch the Italian premium sportswear brand Hydrogen in China. The...

Natural Appetite Suppressant: Why More Are Choosing PhenQ Over Weight Loss Injections for Safer Weight Management Results in 2025

New York City, NY, July 21, 2025 (GLOBE NEWSWIRE) -- PhenQ is leading the 2025 weight loss revolution with a science-backed natural appetite suppressant—no needles, no harsh side effects, just sustainable, healthy weight control

KOSPET Launches Magic Series Smartwatches, Designed for Daily Motion and Urban Style

SHENZHEN, China, July 21, 2025 /PRNewswire/ -- KOSPET today announces the launch of the all-new Magic Series, a smartwatch lineup created for users who...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hims & Hers and Sarepta and Encourages Investors to...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Hims & Hers (HIMS) or Sarepta (SRPT) To Contact Him Directly To Discuss Their Options

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS

NEW YORK, July 19, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the “Class Period”), of the important August 25, 2025 lead plaintiff deadline.

Publicis Groupe : First Half 2025 Results

Very strong Q2 at +5.9% organic growth

ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS

NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the “Class Period”), of the important August 25, 2025 lead plaintiff deadline.

Coveo Is Now Available in the New AWS Marketplace AI Agents and Tools Category

MONTREAL, LONDON and NEW YORK, July 16, 2025 /CNW/ - Coveo (TSX: CVO), the leader in AI-Relevance, delivering best-in-class AI-search and generative experiences that...

Coveo Is Now Available in the New AWS Marketplace AI Agents and Tools Category

MONTREAL, LONDON and NEW YORK, July 16, 2025 /PRNewswire/ - Coveo (TSX: CVO), the leader in AI-Relevance, delivering best-in-class AI-search and generative experiences that...

Parks Associates Announces Call for Papers for the Eighth Annual Future of Video: Business of Streaming, November 18-20 in Marina del Rey

The video service subscription economy generates $106 billion in revenue annually DALLAS, July 16, 2025 /PRNewswire/ -- International research and consulting firm Parks Associates today announced...

ULTIMATE GAME and SOUL M GAME Join Forces to Bring Legendary PC Game IRIS to Mobile — Launching IRIS ORIGIN SEA Exclusively in Southeast...

BANGKOK, July 16, 2025 /PRNewswire/ -- Ultimate Game Co., Ltd., a premier Thai-based online game publisher, has joined forces with Soul M Game Inc.,...

Menin Inhibitors Market Forecasts Signal Strong Uptake of Menin Inhibitors in Hematologic Oncology Across the 7MM During the Forecast Period (2020-2034) | DelveInsight

The menin inhibitor market is poised for rapid growth, with REVUFORJ setting the foundation and a strong pipeline of innovative, genetically targeted therapies on...

Menin Inhibitors Market Forecasts Signal Strong Uptake of Menin Inhibitors in Hematologic Oncology Across the 7MM During the Forecast Period (2020-2034) | DelveInsight

The menin inhibitor market is poised for rapid growth, with REVUFORJ setting the foundation and a strong pipeline of innovative, genetically targeted therapies on...

- A word from our sponsors -

spot_img
HomeTagsPersonalization

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers